Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan.

CONCLUSION: Twelve weeks of LDV/SOF treatment provided an excellent and safe regimen for GT2 CHC infection, particularly in non-cirrhotic patients. PMID: 32891488 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32891488?dopt=Abstract

Source: J Formos Med Assoc - September 1, 2020 Category: General Medicine Authors: Chiu HC, Chiu YC, Yang EH, Chang TT, Chien SC, Wu IC, Wu CH, Cheng PN Tags: J Formos Med Assoc Source Type: research